Financial Metrics Exploration: Understanding Black Diamond Therapeutics Inc (BDTX) Through Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Black Diamond Therapeutics Inc (NASDAQ: BDTX) was $7.20 for the day, down -2.57% from the previous closing price of $7.39. In other words, the price has decreased by -$2.57 from its previous closing price. On the day, 1.01 million shares were traded. BDTX stock price reached its highest trading level at $7.5 during the session, while it also had its lowest trading level at $7.02.

Ratios:

Our analysis of BDTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.82 and its Current Ratio is at 6.82. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.19.

On June 30, 2023, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $2 to $10.

H.C. Wainwright Upgraded its Neutral to Buy on June 28, 2023, while the target price for the stock was maintained at $11.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 17 ’23 when BIOTECH GROWTH N V bought 400,000 shares for $2.34 per share. The transaction valued at 934,080 led to the insider holds 8,517,839 shares of the business.

Behbahani Ali bought 1,000,000 shares of BDTX for $5,000,000 on Jul 05 ’23. The Director now owns 4,448,757 shares after completing the transaction at $5.00 per share. On Jul 05 ’23, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 935,850 shares for $5.00 each. As a result, the insider paid 4,679,250 and bolstered with 3,213,828 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 378218144 and an Enterprise Value of 266266512.

Stock Price History:

Over the past 52 weeks, BDTX has reached a high of $7.66, while it has fallen to a 52-week low of $1.57. The 50-Day Moving Average of the stock is 40.92%, while the 200-Day Moving Average is calculated to be 103.86%.

Shares Statistics:

BDTX traded an average of 668.91K shares per day over the past three months and 857910 shares per day over the past ten days. A total of 51.65M shares are outstanding, with a floating share count of 38.73M. Insiders hold about 26.27% of the company’s shares, while institutions hold 66.11% stake in the company. Shares short for BDTX as of 1713139200 were 1760244 with a Short Ratio of 2.63, compared to 1710460800 on 1812637. Therefore, it implies a Short% of Shares Outstanding of 1760244 and a Short% of Float of 5.9499998.

Most Popular